A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

In patients with relapsing-remitting multiple sclerosis (RRMS), interferon beta-1b (IFNβ-1b) reduces the occurrence of contrast enhancing lesions (CELs) on magnetic resonance imaging (MRI). Questions remain on the stability of IFNβ-1b effect over time and its action beyond the reduction of CELs. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, A, Bagnato, F, Villoslada, P, Velez de Mendizabal, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452935/
https://www.ncbi.nlm.nih.gov/pubmed/26225255
http://dx.doi.org/10.1002/psp4.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452935/
https://www.ncbi.nlm.nih.gov/pubmed/26225255
http://dx.doi.org/10.1002/psp4.36

Ejemplares similares